Knockout experiments confirmed that TIM3-deficient DC cells significantly enhanced the activation and expansion of CD8+ T cells and stem cell-like T cells (TSCM), and promoted anti-tumor immune responses (31). This evidence concerns the gene HAVCR2 and neoplasm.